08:48 AM EDT, 06/23/2025 (MT Newswires) -- Candel Therapeutics ( CADL ) said Monday it has appointed Charles Schoch as chief financial officer, following his service as interim CFO since January.

Prior to Candel, Schoch worked at Corbus Pharmaceuticals ( CRBP ) and PricewaterhouseCoopers, the company said.

Candel said Schoch's appointment backs its objectives, including a planned Biologics License Application for CAN-2409 for prostate cancer.